Issue Date: November 2, 2009
Hikal Branches Out
Despite worries over supply-chain security after incidents of contaminated drugs from Asia last year, most major pharmaceutical companies insist that proven players in India and China will remain a fixture in their active pharmaceutical ingredient (API)-outsourcing strategies. Indian suppliers are particularly well established in the sector, and many had a large presence at CPhI, the pharmaceutical ingredients conference, in Madrid last month.
In fact, the field has become competitive, with firms such . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society